Rollout of COVID-19 Vaccination in India: A SWOT Analysis
- PMID: 33820581
- PMCID: PMC8193205
- DOI: 10.1017/dmp.2021.111
Rollout of COVID-19 Vaccination in India: A SWOT Analysis
Abstract
Objective: This study aimed to identify the strengths, weaknesses, opportunities, and threats (SWOT) in the rollout of the COVID-19 vaccination campaign in India.
Methods: The internal and external attributes affecting the vaccination rollout identifed by reviewing the scientific literature, government guidelines, and press statements, along with media reports, were categorized into the SWOT matrix.
Results: The existing immunization program, indigenous vaccine production, setting up of the National Expert Group on Vaccine Administration for COVID-19, updated guidelines, and training followed by dry runs were identified as strengths. The weaknesses identified in the program were knowledge gap about vaccines, apprehensions, lack of temperature loggers and vaccine vial monitors, space contraints in health care set up, demand supply gap, and digital divide. The experience of conducting the general elections, intersectoral coordination forged during the pandemic response, Information Technology platform, and vaccine eagerness present opportunities to strengthen the program. The emergence of virus variants, commercial interests, laxity in COVID-19 appropriate behavior, and receding wave of the pandemic can pose significant threats to the implementation of the vaccination campaign.
Conclusion: The study identified factors that can aid designing effective measures and countermeasures for the COVID-19 vaccination rollout. This SWOT analysis is relevant to low- and middle-income countries planning to implement the COVID-19 vaccination in the near future.
Keywords: COVID-19 vaccination; SWOT; pandemic.
Similar articles
-
Perspectives on the COVID-19 Vaccination Rollout in 17 Countries: Reflexive Thematic and Frequency Analysis Based on the Strengths, Weaknesses, Opportunities, and Threats (SWOT) Framework.JMIR Hum Factors. 2024 Feb 19;11:e44258. doi: 10.2196/44258. JMIR Hum Factors. 2024. PMID: 38373020 Free PMC article.
-
[SWOT analysis of influenza vaccination promotion of primary care staff based on the perspective of the supplier, customer, and management].Zhonghua Liu Xing Bing Xue Za Zhi. 2022 Jun 10;43(6):953-959. doi: 10.3760/cma.j.cn112338-20220108-00014. Zhonghua Liu Xing Bing Xue Za Zhi. 2022. PMID: 35725355 Chinese.
-
Media Reporting Relating to COVID-19 Vaccination as a Driver of Vaccine Hesitancy Prior to the Second Wave of the COVID-19 Pandemic in India: A Content Analysis of Newspaper and Digital Media Reports.Cureus. 2023 Mar 27;15(3):e36750. doi: 10.7759/cureus.36750. eCollection 2023 Mar. Cureus. 2023. PMID: 37123709 Free PMC article.
-
The Landscape of COVID-19 Vaccination in Zimbabwe: A Narrative Review and Analysis of the Strengths, Weaknesses, Opportunities and Threats of the Programme.Vaccines (Basel). 2022 Feb 9;10(2):262. doi: 10.3390/vaccines10020262. Vaccines (Basel). 2022. PMID: 35214720 Free PMC article. Review.
-
Global cancer surgery in low-resource settings: A strengths, weaknesses, opportunities, and threats analysis.Cancer. 2023 Mar 1;129(5):671-684. doi: 10.1002/cncr.34630. Epub 2023 Jan 3. Cancer. 2023. PMID: 36597652 Free PMC article. Review.
Cited by
-
Perspectives on the COVID-19 Vaccination Rollout in 17 Countries: Reflexive Thematic and Frequency Analysis Based on the Strengths, Weaknesses, Opportunities, and Threats (SWOT) Framework.JMIR Hum Factors. 2024 Feb 19;11:e44258. doi: 10.2196/44258. JMIR Hum Factors. 2024. PMID: 38373020 Free PMC article.
-
A Comparative Study on Survivors Versus Non-Survivors Among Diabetic Patients Having Mucormycosis.Cureus. 2023 Oct 29;15(10):e47932. doi: 10.7759/cureus.47932. eCollection 2023 Oct. Cureus. 2023. PMID: 38034231 Free PMC article.
-
Process Evaluation of COVID-19 Vaccination Sessions in Dadra and Nagar Haveli District During SARS-CoV-2 Pandemic.Indian J Community Med. 2022 Jul-Sep;47(3):410-413. doi: 10.4103/ijcm.ijcm_1405_21. Epub 2022 Oct 10. Indian J Community Med. 2022. PMID: 36438515 Free PMC article.
-
More Than Three-Fourths of AstraZeneca (ChAdox1 COV-19) COVID-19 Vaccinated Individuals Develop Post Immunization Adverse Event in Northwest Ethiopia.Infect Drug Resist. 2022 May 3;15:2409-2416. doi: 10.2147/IDR.S360605. eCollection 2022. Infect Drug Resist. 2022. PMID: 35535029 Free PMC article.
-
Critical prerequisites for Covid-19 vaccine acceleration: A developing economy perspective.J Public Aff. 2021 Nov;21(4):e2723. doi: 10.1002/pa.2723. Epub 2021 Jul 20. J Public Aff. 2021. PMID: 34512185 Free PMC article.
References
-
- Ministry of Health and Family Welfare, Government of India. COVID-19 vaccines operational guidelines. Updated December 28, 2020. https://www.mohfw.gov.in/pdf/COVID19VaccineOG111Chapter16.pdf. Accessed January 18, 2021.
-
- Ministry of Health and Family Welfare, Government of India. National expert group on vaccine administration for COVID-19 deliberates on strategy to ensure COVID-19 vaccines’ availability and its delivery mechanism. August 12, 2020. https://pib.gov.in/PressReleasePage.aspx?PRID=1645363. Accessed January 18, 2021.
-
- Ministry of Health and Family Welfare, Government of India. Frequently asked questions on COVID-19 vaccine. No date. https://www.mohfw.gov.in/pdf/FrequentlyAskedQuestionsonCOVID19vaccineGen.... Accessed January 18, 2021.
-
- Ministry of Electronics and IT, Government of India. IT minister Ravi Shankar Prasad announces launch of Grand Challenge for strengthening the COVID Vaccine Intelligence Network (CoWIN) system. December 23, 2020. https://pib.gov.in/PressReleasePage.aspx?PRID=1683001. Accessed January 18, 2021.
-
- Ministry of Health and Family Welfare, Government of India. Dry run for COVID-19 vaccination successfully conducted in four states. December 29, 2020. https://pib.gov.in/PressReleseDetail.aspx?PRID=1684354. Accessed January 18, 2021.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
